Sumary of New center at UC San Diego to study the effects of antibiotics on mother’s milk and infant health:
- More than 70 percent of breastfeeding women take some form of medication, but 90 percent of those medications are not appropriately labeled for pregnant or lactating women.
- This means the drugs are taken “off-label” or without Food and Drug Administration (FDA) approval, largely because they have never been tested in this population.
- Even less is known about whether these drugs enter the mother’s breast milk or are safe for the baby to consume that way.
- To address these issues, researchers at University of California San Diego School of Medicine have received a $6.1 million grant to launch a new Center of Excellence in Therapeutics (CET).
- UC San Diego joins Vanderbilt University, Indiana University and Ohio State University to form the new Maternal and Pediatric Precision in Therapeutics (MPRINT) Hub funded by the National Institutes of Health (NIH).
- While MPRINT will investigate a variety of therapeutics, initial studies at the UC San Diego center will focus on antibiotics.
- Antibiotics are some of the most frequently used medications by breastfeeding women, and are necessary treatments for many infections.
- However, their effects on child development via breast milk exposure remain largely unknown.